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 INTRODUCTION 
 The diagnosis of Alzheimer’s disease (AD) in clinical and 
research settings relies primarily on the observation of pro-
gressive cognitive and functional decline in the absence of 
other causes of dementia (American Psychiatric Association, 
 1994 ; McKhann, Drachman, Folstein, Katzman, Price, & 
Stadlan,  1984 ;). New research criteria for the diagnosis of 
AD were recently proposed which suggest that early and 
progressive decline in episodic memory with additional 
supporting suggestive features should form the core clin-
ical basis for diagnosis (Dubois et al.,  2007 ). 
 The pattern of cognitive decline in AD typically involves 
early episodic memory impairment, followed by defi cits in 
attention, visuospatial abilities, and language (Alladi et al., 
 2007 ; Petersen,  1998 ) which is believed to correspond to ini-
tial pathology in the medial temporal lobe (particularly the 
entorhinal cortex and the hippocampal formation) with sub-
sequent spread to other neocortical association regions 
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 Abstract 
 Heterogeneity is observed in the patterns of cognition in Alzheimer’s disease (AD). Such heterogeneity might suggest 
the involvement of different etiological pathways or different host responses to pathology. A total of 627 subjects with 
mild/moderate AD underwent cognitive assessment with the Mini-Mental State Examination (MMSE) and the Dementia 
Rating Scale-2 (DRS-2). Latent class analysis (LCA) was performed on cognition subscale data to identify and 
characterize cognitive subgroups. Clinical, demographic, and genetic factors were explored for association with class 
membership. LCA suggested the existence of four subgroups; one group with mild and another with severe global 
impairment across the cognitive domains, one group with primary impairments in attention and construction, and 
another group with primary defi cits in memory and orientation. Education, disease duration, age, Apolipoprotein E- ε 4 
( APOE  ε 4) status, gender, presence of grasp refl ex, white matter changes, and early or prominent visuospatial impairment 
were all associated with class membership. Our results support the existence of heterogeneity in patterns of cognitive 
impairment in AD. Our observation of classes characterized by predominant defi cits in attention/construction and 
memory respectively deserves further exploration as does the association between membership in the attention/
construction class and  APOE  ε 4 negative status. ( JINS , 2010, 16, 233–243.) 
 Keywords :  Dementia ,  Latent class analysis ,  Cognition ,  Mattis Dementia Rating Scale-2 ,  Mini-Mental State Examination , 
 Apolipoprotein E 
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(Alladi et al.,  2007 ; Hodges,  2006 ; Braak & Braak,  1991 ). 
However, heterogeneity is observed both in brain regions af-
fected by AD pathology and in clinical cognitive symptoms 
at presentation. Understanding the basis for this heteroge-
neity could lead to the elucidation of different etiological 
pathways amenable to intervention for the prevention and 
eventually treatment of AD. 
 AD primarily presents as an amnestic syndrome in contrast 
to other dementias such as frontotemporal dementia which may 
present with prominent speech or behavioral disturbances 
(Alladi et al.,  2007 ). Recent studies, however, indicate that con-
siderable AD pathology can be observed in individuals present-
ing with focal syndromes (i.e., specifi c cognitive disturbances 
thought to originate from damage to certain cortical regions) 
(Alladi et al.,  2007 ; von Gunten, Bouras, Kovari, Giannakopou-
los, & Hof,  2006 ) and that these atypical presentations may 
be more common than previously thought (Galton, Patterson, 
Xuereb, & Hodges,  2000 ). Focal presentations described in-
clude posterior cortical atrophy, biparietal syndrome, progres-
sive aphasia, cortical basal syndrome and “frontal” presentations 
involving marked behavioral symptoms and defi cits in execu-
tive function (Alladi et al.,  2007 ; Schott et al.,  2006 ). Contrary 
to the pattern attributed to “typical AD,” amnesia may be a less 
prominent symptom in individuals with focal presentations sug-
gesting relatively lower pathological burden of the medial tem-
poral lobe (Alladi et al.,  2007 ). 
 Several studies have aimed to characterize the heterogeneity 
in the cognitive presentation of AD and to associate this het-
erogeneity with pathologic features (Kanne, Balota, Storandt, 
McKeel, & Morris,  1998 ; Pappas, Bayley, Bui, Hansen, & 
Thal,  2000 ); imaging profi le (Snowden et al.,  2007 ; Stopford, 
Snowden, Thompson, & Neary,  2008 ); regional metabolism 
(Martin et al.,  1986 ); or clinical, demographic, and genetic fea-
tures (Fisher, Rourke, Bieliauskas, Giordani, Berent, & Foster, 
 1996 ; Fisher, Rourke, & Bieliauskas,  1999 ; Jacobs et al.,  1994 ; 
Sevush, Leve, & Brickman,  1993 ; Sevush, Peruyera, Bertran, 
Cisneros,  2003 ; Snowden et al.,  2007 ;). These studies often 
relied on factor or principal components analysis of data from 
cognitive tests believed to sample specifi c functions, or sub-
scales of global scales of cognition. While some studies used 
individuals’ factor scores as the basis for tests of association 
with clinical or pathologic factors (Jacobs et al.,  1994 ; Kanne 
et al.,  1998 ; Pappas et al.,  2000 ; Sevush et al.,  1993 ; Sevush 
et al.,  2003 ), others used cluster analysis of factor scores to 
create homogenous groups of patients for analysis (Fisher 
et al.,  1996 ,  1999 ; Martin et al.,  1986 ; Stopford et al.,  2008 ). 
Findings on the number of cognitive subgroups identifi ed 
and the nature of these groups were not consistent. 
 Factor analysis has certain limitations in exploring sub-
groupings of individuals based on the analysis of cognition 
scores. Factor analysis should be performed on normally dis-
tributed data (Hatcher,  1994 ), and it is likely that data from 
cognitive test scores, and particularly test subscales, may be 
extremely skewed due to fl oor and ceiling effects. Further-
more, the scaling of the different cognition tests or subscales 
may differ, with certain tests having greater inherent vari-
ance and sensitivity to differences between subjects than 
others. This might lead to diffi culties in interpreting the re-
sults of factor analysis. 
 The current study aimed to explore the existence of cogni-
tive subgroups of individuals with AD through the use of la-
tent class analysis of cognitive subscale data collected from 
a large sample of subjects with AD. Latent class analysis 
(LCA) is a probabilistic technique used to detect homoge-
nous subgroupings of individuals based on responses across 
several measured categorical variables (McCutcheon,  1987 ). 
Like factor analysis, it involves measurement of a latent var-
iable but unlike factor analysis, an assumption is made that 
this variable is categorical in nature rather than continuous. 
An additional study aim was to explore potential associa-
tions of cognitive class membership with clinical, demo-
graphic and genetic factors. In particular, we were interested 
in investigating the role of age, disease duration, education 
and Apolipoprotein E- ε 4 ( APOE  ε 4) genotype in predicting 
class membership and in exploring the role of further covari-
ates after adjustment for these factors. 
 METHOD 
 The analysis dataset of AD cases was drawn from a large 
case-control study of 875 AD patients and 850 nondemented 
control subjects recruited from nine Memory Referral Clinics 
in Canada between June 2002 and March 2005 described 
elsewhere (Li et al.,  2008 ). The study protocol included neu-
rological, neuropsychological, and laboratory assessments 
plus medical record review of dementia history (including 
neuroimaging) where available. 
 Inclusion criteria required that AD patients fulfi lled crite-
ria outlined in DSM-IV (American Psychiatric Association, 
 1994 ) and by NINCDS-ADRDA (McKhann et al.,  1984 ) 
criteria for probable AD, with a Global Deterioration Scale 
(GDS) of 3–7 (ranging from mild to very severe cognitive 
decline) (Reisberg, Ferris, de Leon, & Crook,  1982 ). Subjects 
were excluded if they were in a major depressive episode, acute 
psychosis, or acute manic or depressive episode of bipolar 
disorder at the time of recruitment. Neuroimaging was not 
required as part of the study protocol, although imaging at the 
time of AD diagnosis to rule out vascular and other causes of 
dementia would have been expected clinical practice. The study 
protocol was reviewed and approved by the appropriate 
ethics committee (EC) or investigational review board (IRB) 
for each study site before subject recruitment. Informed con-
sent was obtained from study participants in accordance with 
all applicable IRB/EC and regulatory requirements. 
 The present study sample was restricted to 627 mild/mod-
erate AD cases based on a total Mini-Mental State Examina-
tion (MMSE) (Folstein, Folstein, & McHugh,  1975 ) score of 
 ≥ 15, to limit the infl uence of fl oor effects on the cognitive 
scales in severe AD. 
 Cognitive Assessment 
 Cognitive function was assessed with the MMSE (Folstein 
et al.,  1975 ) and the Mattis Dementia Rating Scale-2 (DRS-2) 
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(Jurica, Leitten, & Mattis,  2001 ; Mattis,  1976 ) scales. Scores 
on a total of 11 subscales from these tests were used in LCA 
to derive subgroups of cognitively similar patients based on 
impairment in specifi c cognitive domains. The DRS-2 sub-
scales were defi ned according to Jurica et al. ( 2001 ) as Atten-
tion, Conceptualization, Construction, Initiation/Perseveration, 
and Memory. The MMSE questions were grouped into the 
following categories: attention (spell “WORLD” backward), 
language (object naming, sentence repetition, writing a sen-
tence, read and follow command “Close your eyes”), orienta-
tion (for time and place), memory (registration and recall 
of “apple,” “penny,” “table”), praxis (3-stage command), and 
construction (pentagon copy). 
 Data Analysis 
 Latent class analysis (LCA) of the 11 cognition subscale 
items was used to examine the latent structure of cognition 
in the sample of AD cases. To correct both for differences in 
range of possible scores on each subscale (1–37) which 
might affect weighting of the variable in the analysis, and for 
skewness of subscale score distributions, median total sample 
scores for each subscale were used as cut points to create 
dichotomous indicators for each subscale, corresponding to 
high/low scores based on the sample distribution. Low scores 
on both the MMSE and DRS-2 indicate greater impairment. 
 LCA is a probability-based clustering method which 
assumes that associations between individuals, based on 
responses for the observed items, can be explained by an 
underlying class structure (McCutcheon,  1987 ). This struc-
ture can be characterized through observation of the structural 
model consisting of latent class probabilities ( gamma param-
eters which correspond to latent class prevalence) and the 
measurement model or item response probabilities, condi-
tional on class membership ( rho parameters) (Lanza, Collins, 
Lemmon, & Schafer, 2007a). In the current analysis, the 
 gamma parameters will correspond to the prevalence of each 
cognition class and the  rho parameters, corresponding to 
probability of low scores in each of the measured cognitive 
domains, can be used to infer the cognitive profi le associated 
with class membership. It is assumed that, within each la-
tent class, individual items will be uncorrelated (McCutch-
eon,  1987 ). Selection of the number of latent classes was 
based on consideration of model parsimony, measures of 
goodness of fi t [Bayesian Information Criterion (Schwartz, 
 1978 ), and the Lo-Mendell-Rubin likelihood ratio test (Lo, 
Mendell, & Rubin,  2001 ) as per Nylund, Asparouhov, and 
Muthén ( 2007 )] and substantive interpretation of class meaning. 
Consistency of model identifi cation was examined by altering 
the seed that generates sets of random starting values. 
 Association between class membership and covariates 
was assessed using multinomial logistic regression. Odds 
ratios reflect the increase in odds of class membership 
for each class (relative to a reference class) correspond-
ing to a one-unit increase in the covariate. To characterize 
the classes, a large number of demographic, clinical, and 
 
a
 Copyright © 2002-2003 SAS Institute Inc. SAS and all other SAS 
Institute Inc. product or service names are registered trademarks or trade-
marks of SAS Institute Inc., Cary, NC, USA. 
disease-related factors were tested for association with 
class membership. These are described in  Table 1 . Vari-
ables found to improve model fi t signifi cantly ( p < .05) in 
univariate regression models were then assessed  via mul-
tiple regression models. First, we constructed a “minimal” 
regression model comprising variables believed to have 
the highest potential to confound univariate relationships. 
This “minimal” model included age, education, duration, 
and  APOE  ε 4 genotype. Additional variables that were sig-
nifi cant ( p < .05) in univariate analyses were then assessed 
in turn for association with class membership, after adjust-
ment for the minimal model covariates. 
 The possible confounding effect of disease duration on 
class membership was further assessed by stratifying the 
sample using cut points based on quartiles of disease dura-
tion. The latent class model was run again using duration 
quartile as a grouping variable to allow assessment of the 
probability of class membership within each duration stra-
tum. A test for measurement invariance across groups was 
performed (see Lanza, Collins et al., 2007a ) to ensure that 
the measurement model held across the groups and that this 
analysis was valid. 
 LCA was performed with PROC LCA Version 1.1.3 
(Lanza, Lemmon, Schafer, & Collins, 2007b) using SAS 
software, Version 9.1 for Windows a and was replicated using 
MPLUS Version 5.1 (Muthen & Muthen,  2007 ). Covariate 
modeling was performed using PROC LCA. If data sparse-
ness was highlighted as causing an error in the modeling 
process, the “Stabilize” function of Proc LCA was used, which 
added a data derived prior to stabilize the model (Lanza, 
Lemmon et al.,  2007 b). Only PROC LCA results will be re-
ported here as the class solutions derived were identical. 
 RESULTS 
 The study sample characteristics are summarized in  Table 2 . 
 Review of the model fi t statistics for LCA models fi t se-
quentially with increasing numbers of classes indicated that a 
4-class solution was optimal. The BIC was lowest for this so-
lution and the Lo-Mendell-Rubin test for fi ve classes failed to 
reach statistical signifi cance suggesting that the addition of a 
fi fth class did not improve model fi t. The 4-class solution was 
substantively interpretable and variations in the seed value 
produced the same solution, indicating that the model estima-
tion procedure identifi ed the valid 4-class solution. 
 Class Descriptions 
 The prevalence of each class and the probabilities, condi-
tional on class membership, of being in the lowest scoring 
50% of the study sample for each cognition subscale are pre-
sented in  Table 3 and graphically in  Figure 1 . 
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 Based on review of the pattern of impairment across the 
cognition subscales, the classes were named “Mild,” “Attention/
Construction,” “Memory,” and “Severe.” The Mild class was 
considered to represent a group of subjects with uniformly 
low probabilities of being in the lowest scoring half of the 
sample across all cognitive domains. The Severe class was also 
characterized by a fairly uniform level of impairment across 
all domains with consistently higher impairment across the 
domains relative to all the other classes. The Mild and the 
Severe classes were of nearly equal sizes with each accounting 
for approximately 25% of cases. 
 The other two classes showed distinct patterns of impair-
ment in certain cognitive domains, rather than global mild or 
severe impairment. The Attention/Construction class was dis-
tinguished by predominant defi cits in the attention and, to a 
lesser extent, the construction subscales of both the MMSE and 
the DRS-2 tests. Memory and orientation abilities appeared 
to be spared relative to attention and constructional abilities. 
Conversely, the “Memory” class was associated with predomi-
nant defi cits on the DRS-2 memory and the MMSE memory and 
orientation subscales with relative sparing of attention, construc-
tional, and language abilities. Probabilities for impairment 
on the conceptualization and initiation/perseveration DRS-2 
subscales were fairly high both for the Attention/Construction 
class and the Memory class and these subscales thus did not 
differentiate between these two classes. The Attention/
Construction class was also characterized by impairment 
in the MMSE language subscale relative to the Mild and 
Memory classes with probabilities of impairment similar to 
those for the Severe class. The Memory class was the most 
prevalent, accounting for 35% of cases, while the Attention/
Construction class had the lowest prevalence at 14%. 
 Covariates Associated With Class Membership 
 Univariate multinomial regression models indicated a signifi -
cant role for age, duration, education, and  APOE  ε 4 genotype 
 Table 2.  Sample characteristics – total study sample ( N = 627) 
 Age, mean ( SD )  76.9 (8.48) 
 Duration of AD symptoms, mean ( SD )  4.9 (2.63) 
 GDS score, mean ( SD )  4.1 (0.70) 
 MMSE score, mean ( SD )  22.5 (3.73) 
 DRS-2 score, mean ( SD )  111.2 (15.34) 
 Male gender,  N (%)  267 (42.6) 
 Education level 
 > 15 yr,  N (%)  121 (19.3) 
 11-15 yr,  N (%)  395 (43.7) 
 < 10 yr,  N (%)  232 (37.0) 
 APOE  ε 4 alleles 
 0,  N (%)  226 (38.2) 
 1,  N (%)  290 (49.0) 
 2,  N (%)  76 (12.8) 
 Current use of medications for AD,  N (%)  187 (29.8) 
 Table 1.  Summary of covariates 
 Demographic  Age (yr), male gender (n/y), education level, caffeine use (caffeinated drinks 
 per day), ever drank 5 or more drinks of any kind of alcohol almost 
 everyday? (n/y), ever told by doctor that overweight? (n/y), smoking 
 (pack years) 
 Comorbidities  Hypertension (n/y) : blood pressure > 140/90 or antihypertensive use or 
 reported history of hypertension 
 Cerebrovascular disease (n/y): history of myocardial infarction, angina, 
 stroke or transient ischemia attack 
 Diabetes type 1 or 2 (n/y) : history of diabetes type 1 or type 2 or use of 
 diabetes medications or HbA1c > 6%) 
 Metabolic syndrome (n/y): history of type 2 diabetes or HbA1c > = 5.7 and 
 2 of the following: a) antihypertensive medication and/or high blood 
 pressure ( ≥ 140 mmHg systolic or  ≥ 90 mmHg diastolic), b) Plasma 
 triglycerides  ≥ 2.27 mmol/L, c) HDL cholesterol  ≤ 35 mg/dL (< 0.9 mmol/L) 
 in men or < 39 mg/dL (1.0 mmol/L) in women, c) BMI > 30kg/m 2 and/or 
 waist:hip ratio > 0.9 in men, > 0.85 in women 
 AD features  Duration of disease since symptom onset (yr), current use of AD medication 
 (n/y), ever use of AD medication (n/y), early apraxia (n/y), early/ prominent 
 visuospatial impairment (n/y), early speech abnormalities (n/y), AD with 
 psychotic features (defi ned as meeting DSM-IV criteria for AD with 
 delusions or use of antipsychotic medication), AD with depression (defi ned 
 as meeting DSM-IV criteria for AD with depression or use of antidepressant 
 medication) 
 MRI/ CT features (from most 
 recent scan in medical record) 
 Global atrophy (n/y), focal atrophy (n/y), evidence of white matter change 
 (n/y), evidence of infarcts (n/y) 
 Neurologic exam  Carotid bruits (n/y), frontal gait (n/y), frontal release signs – grasp (n/y), 
 frontal release signs – other (n/y), deep tendon refl exes (normal/ abnormal), 
 plantar responses (normal/abnormal), parkinsonian features (n/y) 
 Genetic/ heritability factors  Family history of memory loss (n/y),  APOE  ε 4 alleles (0,1,2) 
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(the minimum model covariates) in predicting class member-
ship. These variables were entered into a multiple regression 
model ( Table 4 ) and each covariate retained statistical signifi -
cance after adjustment for all other variables. The Mild class 
were on average younger than the Severe and the Memory 
classes and slightly older than the Attention/Construction 
class. The Mild class was also the most highly educated with 
the Severe class having the greatest probability of lower edu-
cation. The Severe class had the longest disease duration while 
the Mild class had the shortest. 
 Individuals in the Mild class were more likely than the 
other classes to have an  APOE  ε 4 allele after adjustment for 
age, education, and disease duration. The Attention/Con-
struction class were the least likely to be  APOE  ε 4 positive. 
These fi ndings were tested further with binary logistic re-
gression modeling which compared each class with all the 
other classes. After adjustment for age, education, and disease 
duration, membership in the Mild class was associated 
with a higher likelihood of an  APOE  ε 4 allele [odds ratio 
(OR) 1.53;  p < .05] than membership in any other class, and 
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 Fig. 1.  Graphic representation of  Table 2 (Conditional Probability of < Median Score on Cognition Subtest by Class). 
 Table 3.  Latent class model 
  Class 1 Mild  Class 2 Attention/Construction  Class 3 Memory  Class 4 Severe 
 Latent Class prevalence ( gamma parameters ) 
  24.4%  14.3%  35.4%  25.9% 
 Probability of <median score on cognition subscale ( rho parameters) 
 DRS-2 subscales 
 Attention  .2165  .7574  .3904  .8376 
 Conceptualization  .1469  .5675  .5596  .8132 
 Construction  .0897  .4224  .0647  .5863 
 Memory  .0493  .1409  .8802  .9683 
 Initiation/Perseveration  .0981  .4669  .5095  .8916 
 MMSE subscales 
 Attention  .1523  .6834  .2504  .7988 
 Construction  .1716  .598  .2443  .731 
 Memory  .2747  .3173  .7047  .7863 
 Language  .0885  .4801  .2616  .5108 
 Orientation  .1902  .1702  .7729  .9324 
 Praxis  .1051  .2228  .1596  .2128 
 Note.  Probabilities greater than .5 presented in bold to illustrate important items. 
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membership in the Attention/Construction class was associ-
ated with a lower likelihood (OR 0.32;  p < .001). 
 Of the additional variables explored, male sex, frontal gait, 
and frontal release signs as observed in the neurological ex-
amination, early/prominent visuospatial impairment, white 
matter changes as indicated on most recent MRI/CT scan, cur-
rent use of medications for AD, and the presence of psychotic 
features were associated with class membership in univariate 
modeling and were, therefore, examined further after adjust-
ment for the minimum model covariates ( Table 5 ). Male sex, 
frontal release signs, early/prominent visuospatial impairment 
and white matter changes remained statistically signifi cant 
( p < .05) after adjustment for age, education, disease duration, 
and  APOE  ε 4 status while the other variables failed to contrib-
ute signifi cantly to model fi t. 
 Those in the Attention/Construction class were more 
likely to be male than those in the other classes. Those in the 
Severe class were more likely than those in other classes to 
show grasp refl exes; a sign consistent with their more ad-
vanced disease status even in this mild/moderate population. 
Early/prominent visuospatial impairment was most common 
in the Attention/Construction class and the Severe class and 
least common in the Memory class. The likelihood of white 
matter changes was lowest in the Memory class and greatest 
in the Severe class. 
 Class Prevalence by Duration Subgroup 
 Figure 2 shows class membership probabilities (or class 
prevalence) generated from LCA conducted with disease 
 Table 4.  Multiple multinomial logistic regression analysis: minimum model ( N = 590) 
 
 Odds ratios (ORs) † 
 p value  Class 1: Mild 
 Class 2: Attention/ 
Construction  Class 3: Memory  Class 4: Severe 
 Age (yr)  Ref  0.99  1.07  1.05  < .001 
 Education (> 15 yr (ref), 
  11-15 yr, < 10 yr) 
 —  2.91  2.32  3.42  < .001 
 Disease duration (yr since 
  symptom onset) 
 —  1.10  1.37  1.43  < .001 
 APOE  ε 4 (alleles)  —  0.26  0.77  0.85  < .001 
 
†
 Odds ratio is odds of class membership relative to Class 1 associated with a one unit increase (continuous variables) or relative to 
reference value (categorical variables), adjusted for all other covariates. 
 Table 5.  Further multinomial logistic regression models: additional variables signifi cant in univariate testing ( p < .05) 
after adjustment for minimum model covariates 
 
 Analysis 
population ( N ) 
 Odds ratios (ORs) † 
 p value 
 Class 1: 
Mild 
 Class 2: Attention/ 
Construction  Class 3: Memory  Class 4: Severe 
 Male gender  590  —  2.09  0.80  0.70  .01 
 Frontal gait *  578  —  2.66  0.95  3.00  .09 
 Frontal release 
 signs - grasp 
 580  —  0.76  1.05  3.88  .01 
 Early/ prominent 
 visuospatial 
 impairment * 
 510  —  2.13  0.92  2.02  .00 
 White matter 
 changes 
 438  —  0.72  0.39  1.16  .02 
 AD with 
 psychotic 
 features 
 590  —  1.90  2.16  3.26  .14 
 Current use of 
 medications 
 for AD 
 590  —  1.29  0.69  0.62  .14 
 * Due to data sparseness, a data-derived prior was applied to stabilize logistic regression model. 
 
†
 Odds ratio is odds of class membership relative to Class 1 associated with a one unit increase (continuous variables) or relative to 
reference value (categorical variables), adjusted for Minimum Model covariates. 
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duration quartile as a grouping variable. The test for measure-
ment invariance was not statistically signifi cant (difference 
in G2 log-likelihood = 156;  df = 132;  p = .08), indicating that 
comparison of class prevalence across duration categories 
was valid because the classes had the same composition 
across the different categories. Prevalence of the Mild class 
dropped across quartiles of disease duration, although this 
pattern was not monotonic, with a slightly increased preva-
lence in the third quartile compared with the second quartile. 
Conversely, prevalence of the Severe class increased with 
increased disease duration, although this increase was not 
particularly marked between quartiles 1 and 2. Prevalence of 
the Attention/Construction class increased with increasing 
disease duration but appeared to peak in the third quartile 
before dropping off in the highest quartile, possibly indi-
cating that as duration progresses those with an Attention/
Construction cognitive pattern assume a more globally se-
vere profi le. No clear pattern was observed for probability of 
membership in the Memory class; the prevalence appeared 
fairly constant across the quartiles of duration although 
lower in the third quartile. 
 DISCUSSION 
 Latent class analysis suggested the existence of four cognitive 
classes in our cross-sectional sample population. Two of the 
classes were characterized by a global pattern of impairment—
one class with mild impairment and the other with severe. 
We did not fi nd separate classes for predominant defi cits in 
visuospatial construction and language respectively; instead 
individuals with deficits in these domains were grouped 
together with those who had predominant defi cits in attention 
in our study, in the class designated Attention/Construction. 
This profi le might be considered to represent a class with 
primary defi cits in executive function, possibly associated 
with greater frontal pathology. The fi nal, and largest, class 
comprised patients with a profi le of predominant memory/
orientation impairment, potentially representing predominant 
medial temporal lobe pathology. 
 Results from previous studies which used statistical 
methods to defi ne typologies of AD based on patterns of 
cognitive impairment in AD differed markedly in their fi nd-
ings. Martin et al. ( 1986 ) applied cluster analytic methods to 
factor analysis of cognition tests from 42 AD patients and 
detected two clusters representing primary defi cits in visu-
ospatial function and in naming abilities. Using a similar 
methodology in two larger studies, Fisher et al. ( 1996 ,  1999 ) 
identifi ed a globally impaired group in addition to groups 
with predominant impairments in visuospatial and naming 
abilities. A recent cluster analysis study identifi ed global 
presentation types and focal presentations with dispropor-
tionate impairment in perceptuospatial ability, executive 
skills, praxis, and language (Stopford et al.,  2008 ). Studies 
using factor analysis scores alone to characterize cognitive 
subtypes also differed in their fi ndings, in terms of both the 
number of unique factors identifi ed and the constructs be-
lieved to be measured by the factors. However, in keeping 
with our fi ndings, several studies identifi ed a memory (or 
memory/naming, memory/orientation) factor (Jacobs et al., 
 1994 ; Kanne et al.,  1998 ; Pappas et al.,  2000 ; Sevush et al., 
 1993 ,  2003 ) and a factor indicating defi cits in attention 
or mental control (Jacobs et al.,  1994 ; Kanne et al.,  1998 ; 
Pappas et al.,  2000 ) . 
 In a principal components analysis of subscale data from 
the MMSE and DRS from 236 AD patients, Jacobs et al. 
( 1994 ) identifi ed an attentional factor and a recall/naming 
factor. Early onset AD cases performed worse on the atten-
tional items while late onset AD cases performed worse than 
early onset cases on measures of recall/naming. These fi nd-
ings correspond to our observation of a younger group with 
attentional defi cits and an older group with predominant 
memory defi cits. The younger group may indeed represent a 
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 Fig. 2.  Class Membership Probabilities as a Function of Duration. 
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group with younger age at onset, as disease duration did not 
differ markedly between the Attention/Construction class 
and the Memory class; however, it is not possible to con-
clude from the current analysis that membership in these 
classes was driven primarily by age at onset. 
 Members of the Attention/Construction class were more 
likely to be male than those in other classes after adjustment 
for age, duration, education and  APOE  ε 4 genotype. This 
could refl ect premorbid differences in cognitive style due to 
social or genetic factors although previous research suggests 
that males might be expected to outperform females in visu-
ospatial tasks such as those required in the MMSE and DRS-2 
construction subscales (Voyer, Voyer, & Bryden,  1995 ). It is 
also possible that there is an interaction between male sex 
and a potential AD disease pathway which manifests as a 
subphenotype with predominant attentional and/or construc-
tional defi cits. 
 The role of  APOE  ε 4 as a risk factor for AD is consistently 
demonstrated but no clear association of this locus with a 
particular cognitive phenotype has been established. In studies 
of normal aging or mild cognitive impairment, associations 
were observed between  APOE  ε 4 and emergent defi cits in 
episodic memory (Bondi et al.,  1995 ), spatial ability and 
naming (Bretsky et al.,  2003 ), working memory/visuospatial 
attention (Greenwood, Lambert, Sunderland, & Parasuraman, 
 2005 ), and orientation and language (Tsai, Gau, Liu, Hsieh, 
Liou, & Hong,  2008 ). There is also evidence from imaging 
studies that  APOE  ε 4 is associated with greater hippocampal 
atrophy in the normally aging population (den Heijer, Oud-
kerk, Launer, van Duijn, Hofman, & Breteler,  2002 ); an area 
that is believed to be involved in memory function. 
 In a sample of 157 AD patients, Smith et al. ( 1998 ) found 
an  APOE  ε 4 effect on measures of memory (learning) and 
verbal comprehension but not on attention, perceptual orga-
nization, or naming. Marra et al. ( 2004 ) found  APOE  ε 4 pos-
itive status to be associated with worse performance on 
measures of learning, verbal memory and general intelli-
gence but only in those with early onset disease. Van der 
Flier, Schoonenboom, Pijnenburg, Fox, and Scheltens ( 2006 ) 
retrospectively classifi ed 100 consecutive AD patients pre-
senting to their clinic into those with memory and nonmem-
ory phenotype based on description of earliest symptoms. 
The memory phenotype was associated with a higher likeli-
hood of  APOE  ε 4 positivity, while those with the nonmem-
ory phenotype were less likely to be  APOE  ε 4 positive. 
Schott et al. ( 2006 ) observed that some patients present with 
“biparietal” AD which is characterized by relatively pre-
served memory function but with impairment in calculation, 
spelling, praxis, and visuoperceptual and visuospatial 
abilities. They assessed the presentation of 39 AD patients 
and deemed 10 to have biparietal presentation according to 
neuropsychological criteria. Those with biparietal presenta-
tion were unlikely to have an  APOE  ε 4 allele leading the 
authors to suggest that an alternative pathological pathway 
might be involved. 
 We did not fi nd clear evidence that probability of mem-
bership in the Memory/Orientation class increased with in-
creasing numbers of  APOE  ε 4 alleles as might have been 
expected if  APOE  ε 4 is primarily associated with a pathway 
that induces defi cits in memory function; instead member-
ship in the Mild class was most highly associated with in-
creased numbers of  APOE  ε 4 alleles. However, our fi nding 
that probability of membership in the Attention/Construc-
tion class decreased with  APOE  ε 4 allele number is consis-
tent with results from van der Flier et al. ( 2006 ) and Schott 
et al. ( 2006 ) in that we have identifi ed a phenotype with less 
memory involvement, which may be associated with a path-
way that is independent of the  APOE  ε 4 allele . 
 In addition to the biparietal presentation described by 
Schott et al. ( 2006 ), frontal presentations of AD, character-
ized by behavioral symptoms and early executive dysfunc-
tion, were described in neuropathological studies (Alladi 
et al.,  2007 ; Johnson, Head, Kim, Starr, & Cotman,  1999 ; 
Kanne et al.,  1998 ; von Gunten et al.,  2006 ;). It is conceiv-
able that the Attention/Construction class may represent 
those with biparietal AD or early frontal or prefrontal lobe 
involvement. It is also possible that this group included mis-
classifi ed cases of frontotemporal or other types of dementia, 
even with the strict adherence to AD diagnostic algorithms 
in our study and at the time of AD diagnosis. Investigation of 
the pathologic or neuroimaging profi le of those with  APOE 
 ε 4-independent disease and nonmemory phenotype would 
be of interest in future studies. 
 Although our analyses of neuroimaging data were limited 
to those with information in the patient record, those in the 
memory class were least likely of any class to have evidence 
of white matter changes on MRI or CT and those with glob-
ally severe disease were most likely to have changes of this 
kind. It would be interesting to assess the role of vascular 
pathology as a source of heterogeneity in AD cognitive pre-
sentation and, specifi cally, to assess whether a persistent, 
singular memory impairment is indicative of a “purer” AD 
pathology. 
 Age and education were both signifi cant predictors of 
class membership in our study. We chose to use unadjusted 
raw scores because age- and education-adjusted norms were 
not available for our MMSE subscales and because we were 
interested in exploring the contribution of these variables to 
class membership rather than in controlling their impact 
 a priori . Age-associated decline in cognitive performance, 
independent of the decline in cognitive abilities associated 
with the AD disease process, may be associated with a spe-
cifi c pattern of defi cits which may have obscured the pattern 
of defi cits attributed to AD. After adjustment for age, educa-
tion duration was highest in the mild group and lowest in the 
severe group. It is possible that high education may have 
masked defi cits in certain cognitive domains and lower edu-
cation may have led to the spurious fi nding of impairment. 
However, the extent to which education introduces a mis-
classifi cation bias which should be controlled or is actually 
implicated in the pathological processes of AD is unclear 
(Tombaugh & McIntyre,  1992 ). 
 Although the presence of psychotic features appeared 
to be associated with membership in the severe class, this 
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association did not hold after adjustment for age, duration, 
education, and  APOE  ε 4 status. We were unable to detect any 
association between depression in AD and class membership. 
It is possible, however, that our capture of these features was 
insuffi ciently sensitive or, conversely, that the inclusion of 
medication use in the criteria for identifying patients with 
these features led to the inclusion of individuals with com-
pletely controlled symptoms, masking any potential effect. 
Furthermore, the study excluded subjects with acute depres-
sion or psychosis, which could potentially refl ect behavioral 
subgroups. 
 While no association was detected between reported cur-
rent use of medications indicated for the treatment of AD 
and class membership after adjustment for the minimum 
model covariates, a role for medication use in contributing to 
latent class membership cannot be ruled out. We did not an-
alyze the effects of individual drugs or drug classes, and it is 
possible that these contributed to a certain cognitive profi le 
to the extent that they may improve performance or reduce 
decline differentially across the cognitive domains. It is also 
possible that other medications commonly taken by the el-
derly may have affected cognitive performance, and the effect 
of this is diffi cult to ascertain. 
 The current study has several limitations. First, the MMSE 
and the DRS-2, while widely used screening tools for cogni-
tion, are crude instruments for measuring the cognitive do-
mains in their subscales. Scaling in the latent class models as 
binary variables with cutoffs at the median potentially loses 
information relative to other approaches that consider the 
scores as continuous variables. Incorporating further neurop-
sychological testing as well as other cognitive domains may 
lead to a more refi ned classifi cation. The cross-sectional study 
design and enrollment of subjects with different disease dura-
tions is a further limitation as it is not possible to ascertain 
whether individuals in the Attention/Construction and Memory 
classes had demonstrated a globally mild profi le earlier in 
their disease or would develop a globally severe profi le over 
time. Future longitudinal studies could enroll AD patients 
with recent onset of disease and could assess changes in class 
membership over time using latent transition analysis, an ex-
tension of the latent class analysis method (Lanza, Collins 
et al., 2007a). Ceiling and fl oor effects of cognitive scales may 
make patterns diffi cult to detect at early and late stages of 
disease, and learning effects on cognitive tests may compro-
mise accurate description of affected and unaffected domains 
over time (Zehnder, Blasi, Berres, Spiegel, & Monsch,  2007 ). 
Finally, use of the DSM-IV and NINCDS-ADRDA criteria to 
defi ne our AD sample may have yielded a research sample 
that was specifi c for AD but not fully representative of AD in 
clinical settings where mixed dementia and atypical AD pre-
sentations may be more common. This might have led to the 
exclusion of other latent classes which might be identifi ed in a 
clinical setting. 
 An interesting point to consider is whether the underlying 
latent variable(s) inferred to exist through latent class 
analysis of cognition measures would truly be categorical in 
nature. Traditional factor analysis assumes a continuously 
distributed latent variable whereas latent class analysis as-
sumes the latent variable to be categorical. The question is 
equivalent to asking whether inferred cognitive subtypes 
represent truly distinct categories, or arbitrary subdivisions 
of a spectrum. The answer to this is currently unclear given 
our current understanding of functional neuroanatomy and 
the etiology of cognitive defi cits in AD. To the extent that a 
pattern of cognition, for example a defi cit in attentional 
abilities, is driven by pathology in a certain brain region or 
the presence of a certain type of pathology, it is reasonable to 
suggest that the latent variable is categorical. It may also be 
that a certain threshold of pathology in an area must be 
reached for symptoms of loss to be detectable through tests 
of cognitive ability and this would give rise to a categorical 
latent variable. Finally, if unique patterns of cognitive defi -
cits derive from pathology which is caused by genetic or 
other categorical risk factors, the latent variable could be cat-
egorical in nature. 
 In summary, our latent class analysis fi nding of multiple 
classes with unique cognitive profi les confi rms the existence 
of heterogeneity in patterns of cognitive impairment in AD. 
To our knowledge this is the fi rst application of latent class 
analysis to cognitive measures in AD. Several hypotheses 
have been suggested through this exploratory study that 
could be tested in future studies. In particular, class member-
ship transitions should be explored over time, and the cognitive 
phenotype, pathological correlates, and potential etiology 
associated with  APOE  ε 4-negative AD should be further 
investigated. 
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